Vaccination strategies – Page 10 – Communicable Diseases Research

B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19

이전 COVID-19 유무에 관계없이 의료 전문가의 SARS-CoV-2 예방 접종에 대한 B 및 T 세포 반응

Research Paper

Published on 2021-08-122022-09-11
Journal: EBioMedicine [Category] MERS, SARS, 변종, 진단, 치료법,

Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines

Article

Published on 2021-08-042022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] Adaptive immune response Adenovirus adenovirus vaccine adenovirus-based vaccine Administered administration antibody approaches approval boost clinical trial comparable COVID-19 COVID-19 recovered patients dosage dose dose-dependent Effect global pandemic IgG antibody immune response immunological include low dose mathematical mathematical modeling mRNA neutralizing antibody neutralizing antibody (NAb) outcome Particles prime-boost interval promoted Protective recent reducing regimen response Result SARS-CoV-2 second dose Standard dose stimulated the SARS-CoV-2 Vaccination strategies Vaccine vaccine dose vaccine doses Vaccines Viral vector
[DOI] 10.3390/vaccines9080861 PMC 바로가기 [Article Type] Article

SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges

IBD의 SARS-CoV-2 예방 접종: 과거 교훈, 현재 증거 및 미래 과제

Review

Published on 2021-08-022022-09-11
Journal: Journal of Crohn's & colitis [Category] SARS, 변종,

Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia

호주, 감염 6개월 후 소아에서 SARS-CoV-2-특이적 IgG의 지속성

Research Letter

Published on 2021-08-012022-09-10
Journal: Emerging Infectious Diseases [Category] MERS, 진단, 치료기술,

Are We Paving the Way to Dig Out of the “Pandemic Hole”? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization

우리는 "팬데믹 홀"을 파헤치기 위한 길을 닦고 있습니까? SARS-CoV-2 백신 접종에 대한 내러티브 검토: 동물 모델에서 인간 예방 접종까지

Review

Published on 2021-07-302022-09-10
Journal: Medical Sciences [Category] 비임상, 임상,

[키워드] acute respiratory syndrome animal animal model animal models approach breath Clinical studies clinical study clinical trial clinical trials company contributed coronavirus coronavirus 2 COVID-19 develop effective vaccine extreme Government herd immunity high mortality rate Human human immunization humans immune responses Immunity immunization Inactivated Vaccines induce Infectious disease International mechanism Model morbidity and mortality narrative pandemic pathogen Preclinical preclinical studies preclinical study Prevent Protective provide Research respiratory review robust Safe SARS-CoV-2 SARS-CoV-2 pathogenesis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Spectrum therapeutic intervention therapeutic interventions Vaccination strategies Vaccine Vaccines Viral Viral vector vaccines virus
[DOI] 10.3390/medsci9030053 PMC 바로가기 [Article Type] Review

Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa

인공 지능과 빅 데이터를 활용하여 아프리카의 COVID-19 임상 공중 보건 및 백신 출시 전략 최적화

Editorial

Published on 2021-07-262022-09-10
Journal: International Journal of Environmental Research an [Category] SARS, 변종,

Modeling vaccination strategies in an Excel spreadsheet: Increasing the rate of vaccination is more effective than increasing the vaccination coverage for containing COVID-19

Research Article

Published on 2021-07-192022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS,

SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

SARS-CoV-2 항체 역학 COVID-19 발병 후 8개월: 회복기 혈장 공여자의 24%에서 스파이크 항체는 지속되지만 중화 항체 손실

Clinical Trial

Published on 2021-07-012022-09-11
Journal: European journal of internal medicine [Category] SARS, 임상, 진단, 치료기술, 치료법,

[키워드] Analysis anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies antibody Antibody Response Antibody responses Antigen antigens Characteristics contraction convalescent plasma COVID-19 decrease Donor eight faster Follow-up Hospitalization human immune response Immunity intervals linear median monitoring Multivariate analysis multivariate regression analysis neutralization ability Neutralizing Neutralizing antibodies neutralizing antibody nucleocapsid Older age participated Patient persistence Phase 2 Phase 2 study random-effect regression analysis response Result SARS-CoV-2 SARS-CoV-2 antibody spike symptom onset symptoms onset tested Vaccination strategies Vaccine
[DOI] 10.1016/j.ejim.2021.05.010 PMC 바로가기 [Article Type] Clinical Trial

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

건강한 젊은 성인의 SARS-CoV-2 혈청 양성 및 후속 감염 위험: 전향적 코호트 연구

Article

Published on 2021-07-012022-09-11
Journal: The Lancet. Respiratory Medicine [Category] MERS, SARS, 진단, 치료기술,

[키워드] 95% CI Action Analysis antibody baseline COVID-19 COVID-19-related symptom cycle threshold defined Dilution domain effective ELISA enrolled Follow-up full-length spike protein groups hazard ratio healthy home quarantine hotel IgG Immunity incidence rate individuals infected with SARS-CoV-2 Infection infection risk information initial investigated island male mass vaccination medical history men neutralisation activity neutralising neutralising antibody titre observation ORF1 ORF1ab gene participant Participants PCR PCR test person-year positive positive PCR test prospective cohort study Prospective Study Protective quarantine Quarantine period question questionnaire rate ratio Receptor-binding domain response risk Risk factors SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection selected serology test seronegative seronegative participant seronegative participants seropositive seropositive participant seropositive participants Seropositivity serum Spike protein study visit subsequent Swab Symptom tested titre uninfected uninfected participant Vaccination strategies Viral Viral load viral loads was performed were assessed were excluded
[DOI] 10.1016/S2213-2600(21)00158-2 PMC 바로가기 [Article Type] Article

Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates

임산부와 신생아의 중증 급성 호흡기 증후군 코로나바이러스 2 혈청학적 수치

Article

Published on 2021-07-012022-09-11
Journal: American journal of obstetrics and gynecology [Category] SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect Analysis antibody antibody levels Asymptomatic asymptomatic infection baby Birth characterized conducted convalescent convalescent infection Cord blood coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 infection demonstrated dependent on determine disease severity hospital identify immune response immune system Immunity Immunoglobulin Immunoglobulin G immunoglobulin M inclusion criteria Infection Linear regression Local log marker maternal antibodies maternal antibody mother mother-baby dyads Multiple linear regression multiple linear regression analysis Neonatal Neonate Neonates New York City oxygen oxygen support passive immunity Patient patient cohort Pearson correlation Population positive predicted Predictive predictor pregnant women Prevalence Quantitative respiratory responses retrospective serologic antibody Serologic response serology severe acute respiratory syndrome Coronavirus subset susceptible Symptom symptom onset symptomatic symptomatic and asymptomatic symptomatic and asymptomatic patients symptomatic infection Symptoms T Test tested the timing These data time course Umbilical cord umbilical cord blood Vaccination strategies viral infections Vulnerable populations women
[DOI] 10.1016/j.ajog.2021.01.016 PMC 바로가기 [Article Type] Article